REMC - ETF AI Analysis
Top Page
Columbia Research Enhanced Mid Cap ETF (REMC)
REMC, the Columbia Research Enhanced Mid Cap ETF, earns a solid overall rating, helped by strong contributors like Comfort Systems USA (FIX) and Delta Air Lines (DAL), which both show robust financial performance, revenue growth, and positive earnings call sentiment. Other holdings such as Phillips 66 (PSX), Allstate (ALL), and Anglogold Ashanti (AU) also support the fund with stable balance sheets, attractive valuations, and generally positive trends, though some names like Snowflake (SNOW) and Cardinal Health (CAH) face challenges around profitability, leverage, or rich valuations that temper the fund’s overall appeal. The main risk factor is that several holdings show valuation or technical caution signals, meaning parts of the portfolio could be sensitive to market pullbacks or shifts in sentiment.
REMC vs. SPDR S&P 500 ETF (SPY)
- AUM
- 5.85M
- Region
- North America
- Expense Ratio
- 0.32%
- Beta
- 0.50
- Issuer
- Columbia
- Inception Date
- Dec 11, 2025
- Dividend Yield
- 0.07%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
REMC Summary
Columbia Research Enhanced Mid Cap ETF (REMC) is an exchange-traded fund that focuses on U.S. mid-sized companies, aiming for long-term growth. It doesn’t track a standard index; instead, it uses Columbia’s own research to pick a mix of mid-cap stocks across many sectors, including technology, industrials, and health care. Well-known holdings include Phillips 66 and Snowflake. Someone might invest in REMC to tap into the growth potential of mid-sized companies while staying diversified across industries. A key risk is that mid-cap stocks can be more volatile and can go up and down with the overall stock market.
How much will it cost me?
This ETF has an expense ratio of 0.32%, which means you’ll pay about $3.20 per year for every $1,000 you invest. That’s a bit higher than the average low-cost index ETF because this fund is actively managed using Columbia’s research to pick mid-cap stocks rather than simply tracking an index.
What would affect this ETF?
This U.S. mid-cap ETF could benefit if the economy grows steadily, since many of its industrial, technology, and consumer-focused companies, as well as holdings like Hilton and Electronic Arts, tend to do well when business activity and consumer spending are healthy. On the other hand, an economic slowdown, higher interest rates that pressure real estate and financial stocks, or weaker energy prices that hurt companies like Valero and Marathon Petroleum could weigh on future returns.
REMC Top 10 Holdings
This mid-cap U.S. fund leans into a mix of tech, energy, and real-economy names, with a few stocks doing the heavy lifting. Datadog and Snowflake are the flashy tech engines, with Datadog rising and Snowflake more mixed but still adding some spark. Phillips 66 and Occidental Petroleum are powering gains from the energy side, while Cardinal Health provides steady health care ballast. On the flip side, Simon Property and Comfort Systems have been lagging lately, acting like a bit of a headwind in an otherwise broadly diversified, U.S.-focused portfolio.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Phillips 66 | 2.84% | $166.22K | $112.99B | 108.51% | 73Outperform | |
| Snowflake | 1.89% | $110.51K | $114.81B | 28.63% | 54Neutral | |
| Occidental Petroleum | 1.55% | $90.81K | $64.15B | 49.65% | 67Neutral | |
| Simon Property | 1.53% | $89.27K | $68.47B | 18.42% | 70Outperform | |
| Datadog | 1.49% | $87.12K | $96.82B | 72.20% | 69Neutral | |
| Allstate | 1.47% | $85.76K | $64.02B | 30.20% | 74Outperform | |
| Cardinal Health | 1.35% | $78.74K | $57.79B | 56.80% | 66Neutral | |
| Anglogold Ashanti PLC | 1.16% | $67.90K | $42.21B | 21.83% | 73Outperform | |
| Kroger Company | 1.31% | $76.90K | $39.43B | -2.75% | 56Neutral | |
| Becton Dickinson | 1.24% | $72.55K | $54.18B | 6.64% | 67Neutral |
REMC Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For REMC, the sentiment is Positive. The current price of 23.28 is above the 20-day moving average (MA) of 23.01, above the 50-day MA of 23.15, and above the 200-day MA of 21.82, indicating a bullish trend. The MACD of 0.08 indicates Negative momentum. The RSI at 56.05 is Neutral, neither overbought nor oversold. The STOCH value of 92.01 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for REMC.
REMC Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| $23.28 | $25.00(7.40% Upside) | $5.85M | 0.32% | 69Neutral | |
| $24.20 | $28.75(18.79% Upside) | $52.45M | 0.80% | 72Outperform | |
| $27.16 | $31.70(16.73% Upside) | $37.17M | 0.59% | 68Neutral | |
| $25.49 | $31.68(24.26% Upside) | $11.52M | 0.47% | 67Neutral | |
| $25.62 | $29.50(15.11% Upside) | $10.38M | 0.79% | 67Neutral | |
| $66.52 | $79.36(19.30% Upside) | $8.04M | 0.35% | 68Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| REMC | Columbia Research Enhanced Mid Cap ETF | 23.28 | 2.77 | 13.53% | |
| KMID | Virtus KAR Mid-Cap ETF | 24.20 | -0.60 | -2.42% | |
| MMID | MFS Active Mid Cap ETF | 27.16 | 2.21 | 8.85% | |
| TMID | T. Rowe Price Mid Cap Equity Research ETF | 25.49 | 0.24 | 0.97% | |
| SMCP | SMART Mid Cap ETF | 25.62 | 0.75 | 3.03% | |
| MCDS | JPMorgan Fundamental Data Science Mid Core ETF | 66.52 | 8.65 | 14.94% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.